openPR Logo
Press release

Transplant Diagnostics Market is Projected to Reach Valuation Of US$ 1,127.6 Million By 2025

04-25-2018 09:56 AM CET | Health & Medicine

Press release from: Medical Devices Report

Transplant Diagnostics Market is Projected to Reach Valuation

The Global Transplant Diagnostics Market, By Product Type (Instrument, Reagents & Kits, and Software), By Technology (Molecular Assay (PCR-Based and Sequencing – Based), and Non-Molecular Assay), By Application (Tissue Typing, Infectious Disease Testing, Serum-Cross Matching, and Blood Profiling), By Organ Type (Kidney, Liver, Heart, Lungs, Pancreas, and Others), By End User (Hospitals & Transplant Centers, Research Laboratories & Academic Institutes, and Commercial Service Providers), and By Region (North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa) was valued at US$ 544.2 million in 2016 and is projected to exhibit a CAGR of 8.4% over the forecast period (2017–2025), as highlighted in a new report published by Coherent Market Insights. Growth of the transplant diagnostics market is attributed to rising prevalence of chronic diseases leading to multiple organ failures, possible prediction of organ rejection episodes with the help of transplant diagnostics, initiatives by government organizations to promote organ donation, and increasing research and development by leading players to enhance technologies in transplant diagnostics.

Request Sample Copy of Research @ https://www.coherentmarketinsights.com/insight/request-sample/1335

Manufacturers are focusing on introducing innovative transplant diagnostic solutions in line with needs and demands of customers. For instance, Thermo Fisher Scientific launched NXType NGS HLA typing assay in 2015 consisting of SSP, SSO, and SBT molecular typing technologies. Also, Immucor, Inc. launched MIA FORA NGS Flex HLA Typing Assay in 2017, which provides coverage of up to 11 HLA genes. Furthermore, Immucor, Inc. launched kSORT—a molecular gene expression assay—in 2016 for kidney transplant patients. Moreover, Qiagen launched GeneReader NGS system in 2015 that provides NGS solution and helps laboratories in obtaining accurate results. CareDx, Inc. launched Olerup QTYPE in 2016, which is an easy-to-use alternative for rapid HLA typing. Furthermore, GenDx signed a global reseller agreement with Thermo Fisher Scientific in 2017, under which former gained rights to offer latter’s Ion Torrent next-generation sequencing systems.

Browse 48 Market Data Tables and 37 Figures spread through 187 Pages and in-depth TOC on Transplant Diagnostics Market by Product Type (Instrument, Reagents & Kits, and Software), by Technology (Molecular Assay (PCR-Based, Sequencing – Based), and Non-Molecular Assay), by Application (Tissue Typing, Infectious Disease ,.Testing, Serum-Cross Matching, and Blood Profiling), by Organ Type (Kidney, Liver, Heart, Lungs, Pancreas, and Others), by End User (Hospitals & Transplant Centers, Research Laboratories & Academic Institutes, and Commercial Service Providers) and Region (North America, Latin America, Europe, Asia Pacific, the Middle East, and, Africa) - Global Forecast to 2025

Manufacturers are increasingly focusing on research and development of transplant diagnostic products through mergers and acquisition activities. For instance, Thermo Fisher Scientific acquired Linkage Bio in 2017, which became a part of formers transplant diagnostics business, One Lambda. Xenotransplantation (from different species) could aid in reducing the gap in supply and demand of transplant organs. Research on innovative transplant options such as pig-to-human transplants and stem cell transplants is being conducted by various manufacturers. TAI Diagnostics, Inc., which provides a highly sensitive and non-invasive diagnostic test to monitor transplanted organs, entered into a partnership with United Therapeutics and raised significant capital in January 2018 for R&D. Moreover, Transplant Genomics, Inc. entered into a collaboration with Mayo Clinic Center, to develop diagnostic tests for organ transplant patients; in an immunosuppressive clinical trials collaboration with Astellas Pharmaceuticals; and with Quark Pharmaceuticals, in discovery and development collaboration in the year 2016. Natera, Inc. and University of California, San Francisco (UCSF), entered into a research collaboration in 2016, to study DNA markers of Kidney Transplant Rejection.

Ask for customization: https://www.coherentmarketinsights.com/insight/request-customization/1335

Key Takeaways of the Transplant Diagnostics Market:

The global transplant diagnostics market is expected to exhibit a CAGR of 4% over the forecast period (2017–2025), owing to increasing product offerings by key players such as Thermo Fisher Scientific, and Qiagen in transplant diagnostics

Increasing competition in the market has led to increasing focus of key players on continuous product development, in order to enhance their market share. This is expected to aid in market growth over the forecast period.

Increasing effectiveness of transplant diagnostics tests such as identification of more robust biomarkers in providing viable results in organ transplant is expected to boost growth of the transplant diagnostics market over the forecast period

Major players operating in the global transplant diagnostics market are Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Qiagen N.V., F. Hoffman-La Roche Ltd., Immucor, Inc., Becton Dickinson and Company, bioMérieux S.A., Illumina, Inc., CareDx, Inc., and GenDx.

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

1001 4th Ave,
#3200
Seattle, WA 98154

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Transplant Diagnostics Market is Projected to Reach Valuation Of US$ 1,127.6 Million By 2025 here

News-ID: 1029491 • Views:

More Releases from Medical Devices Report

Biopharmaceutical Contract Manufacturing Market – Global Industry Insights, Trends, Outlook, and Analysis, 2017 – 2025
Biopharmaceutical Contract Manufacturing Market – Global Industry Insights, Tr …
Contract manufacturing organizations (CMOs) provide wide range of manufacturing services, which include contract packaging, quality testing, and development service to pharmaceutical and biotechnology industries. Biopharmaceutical companies prefer CMOs due to complexity in manufacturing process of biomolecules, as they consists of different shape, size, and behavior with significantly complex process than pharmaceutical drugs. Contract manufacturing organizations provide services from development of biologics to commercial scale production. Few companies also provide cell
Bioabsorbable Stents Market - Global Industry Insights, Trends, Outlook, and Analysis, 2017-2025
Bioabsorbable Stents Market - Global Industry Insights, Trends, Outlook, and Ana …
The increase in prevalence of cardiovascular diseases globally is the major driving factor for the growth of bioabsorbable stents market. Additionally, increase in risk of late stent thrombosis, and restenosis due to use of conventional drug eluting stents is stimulating the use of new advanced biodegradable stents which degrades after a period. According to American Heart Association (AHS) in 2008, the mortality rate due to late stents thrombosis was around
Audiology Devices Market - Global Industry Insights, Trends, Size, Share, Outlook, and Analysis, 2017–2025
Audiology Devices Market - Global Industry Insights, Trends, Size, Share, Outloo …
Deafness is encountered mainly as a result of an impairment in the ear or damage to the nerves associated with hearing. The causes for these defects may range as congenital defect, injury, disease, side effects of medications, age-related factors, exposure to loud noise, and others. Audiology devices refers to assistive tools that helps a person to enhance its hearing ability under certain medical conditions that results into inability to hear.
Anti-Snoring Treatment Market - Global Industry Insights, Trends, Outlook, And Analysis, 2017-2025
Anti-Snoring Treatment Market - Global Industry Insights, Trends, Outlook, And A …
Snoring is the vibration of respiratory structures which results in sound while sleeping. It is a sleeping disorder caused due to monotonous narrowing and collapsing of the upper airway. Snoring have various adverse effects on health include coronary artery disease, systemic hypertension, atrial fibrillation, and stroke. Snoring is one of the factors of sleep deprivation, which may be further caused due to throat weakness, mis-positioned jaw, obesity, and obstruction in

All 5 Releases


More Releases for Transplant

Global Tacrolimus Injection Market Size, Share & Trends Analysis Report, By Appl …
The global tacrolimus injection market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Tacrolimus, also known as Prograf, is an immunosuppressive drug primarily used with other medications to prevent rejection of a heart, kidney, or liver transplant in adult and pediatric patients. This medication works by supporting the body to accept the new organ and lower the risk of organ rejection so as to prevent
Organ Transplant Market | Organogenesis Incorporated, Terumo Co., OrganOX, Trans …
Organ Transplant Market report is an in-depth analysis study offered which explains necessary aspects like competition, segmentation, and regional growth in excessive detail. As a part of competitive analysis, the analysis study includes thorough company identification of leading players of the world Organ Transplant Market. Organ Transplant Market report provides emerging opportunities in the market and the future impact of major drivers and challenges and, support decision makers in making cost-effective
Transplant Diagnostics Market
Transplant diagnostics is the examination of factors associated with recently performed transplant. This can be elaborated as safety testing, compatibility, testing, transplant feasibility testing, pre, peri, and post transplantation. This is done to check the tissue compatibility between the donor and patient in organ transplant. Major Players: The prominent players in the transplant diagnostics market are Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., QIAGEN, F. Hoffmann-La Roche Ltd., Illumina, Inc., Merck KGaA,
Kidney Transplant Market
Kidney Transplant Market describes its growth, size, share, Forecast and trends to 2025 Kidney transplant is the most commonly conducted transplant surgery worldwide. It has gained widespread popularity by improving the outcome of end-stage renal disease ESRD patients. With advances in kidney transplant methods and improvement in transplant success, a kidney transplant is now widely considered to be the best way of treating chronic kidney disease for many people. As the
hair transplant services
Hair transplant is a surgical procedures that moves hair follicles from one part of the body to another part of the body. Hair transplantation is chiefly used to treat the baldness in male and female. The global hair transplant services market is witnessing a rise in its demand. The market is segmented into three major transplant procedures like scalp reduction, follicular unit strip surgery and follicular unit extraction. Increasing importance regarding
Organ Transplant Immunosuppressant Drugs Market By Drug Class, By Transplant, By …
This report on the organ transplant immunosuppressant drugs market studies the current and future prospects of the global market. Organ transplant immunosuppressant drugs market are prescribed to patients during or after transplant of organs such as kidney, liver, heart, lung and bone marrow. Organ dysfunction caused due to severe injuries, cancer, organ failure and/or genetic disorders necessitate the requirement for organ transplant procedures. Thus, rise in the number of